logo

Kempharm, Inc (KMPH)



Trade KMPH now with
  Date
  Headline
5/19/2020 7:35:44 AM KemPharm Receives Day-74 Letter For KP415 NDA; FDA Sets PDUFA Date Of March 2, 2021
2/28/2020 7:35:20 AM KemPharm Q4 Net Loss $6.0 Mln Or $0.18 Per Share
12/18/2019 7:25:58 AM KemPharm Reports Debt Restructuring With Deerfield And Delaware Street Capital
1/29/2019 7:36:04 AM KemPharm Says Enhancements To U.S. And Global Intellectual Property Estate; Patents Extend Across Prodrug Portfolio
1/18/2019 7:33:26 AM KemPharm Presents Four Scientific Posters At APSARD's 2019 Annual Meeting
1/7/2019 7:38:54 AM KemPharm Says FDA Approves SNDA For Two Additional Strengths Of APADA
10/5/2018 9:29:06 AM KemPharm Prices Public Offering Of 8.33 Mln Common Shares At $3.00 Per Share
10/4/2018 4:08:27 PM KemPharm Announces Proposed Public Offering Of Common Stock
9/17/2018 7:33:48 AM KemPharm Announces Positive Topline Results From Intranasal Human Abuse Potential Trial Of KP415 Prodrug
9/11/2018 7:31:15 AM KemPharm Announces Positive Topline Results From Oral Human Abuse Potential Trial Of KP415 Prodrug
3/20/2018 7:33:43 AM KemPharm Announces Positive Topline Results From KP415 Pharmacokinetic Study In Children And Adolescents With ADHD